Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1994-12-01
1997-04-22
Daus, Donald G.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
514252, 544114, 544238, A61K 3150
Patent
active
056229488
ABSTRACT:
Pyrrole pyridazine and pyridazinone compounds are described. These compounds are useful as anti-inflammatory agents in the treatment of inflammation and pain. The preparation of these compounds, their pharmaceutically acceptable salts, and pharmaceutical compositions containing these compounds, is also described.
REFERENCES:
patent: 3586681 (1971-06-01), Houlihan
patent: 3726978 (1973-04-01), Houlihan
patent: 3752826 (1973-08-01), Carson
patent: 4089969 (1978-05-01), Muchowski et al.
patent: 4247551 (1981-01-01), Bellasio et al.
patent: 4347187 (1982-08-01), Muchowski et al.
patent: 4766121 (1988-08-01), Ellis et al.
patent: 4816454 (1989-03-01), Zoller
patent: 4992441 (1991-02-01), Scott
patent: 5086052 (1992-02-01), Brooks et al.
patent: 5332736 (1994-07-01), Carmosin et al.
Meade, et al., Journal of Biological Chemistry, vol. 268:9 6610-6614 (Mar. 25, 1993, "Differential Inhibition of Prostaglandin Endoperoxide Synthase (Cyclooxygenase) Isozymes by Aspirin and Other Non-steroidal Anti-inflammatory Drugs".
Miller, et al.,Biochemical and Biophysical Research Communications, vol. 201:1, 356-362, (May 30, 1994), "The Heterologous Expression and Characterization of Human Prostaglandin G/H Synthase-2 (COX-2)".
Mitchell, et al., Proc. National Academy of Science, vol. 90: 11693-11697 (Dec. 1994), "Selectivity of nonsteroidal antinflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase".
O'Neill, et al., Molecular Pharmacology, vol. 45: 245-254, (Nov. 3, 1993), "Overexpression of Human Prostaglandin G/H Synthase-1 and -2 by Recombinant Vaccinia Virus: Inhibition by Nonsteroidal Anti-inflammatory Drugs and Biosynthesis of 15-Hydroxyeicosatetraeonoic Acid".
Futaki, et al., Abstract No. 389, 8th International Conference on Prostaglandins and Related Compounds, Montreal, Canada (Jul. 26-31, 1992), "Pharmacological Studies of NS-389: A Newly synthesized Nonsteroidal Anti-inflammatory Drug With Selective Inhibition of Prostaglandin Synthesis In Inflamed Tissue,".
W.H. Rooks II et al., "The analgesic and anti-inflammatory profile of (.+-.)-5-benzoyl-1,2-dihydro-3H-pyrrolo[1,2-a]pyrrole-1 carboxylic acid (RS-37619)", Agents and Actions, 12(5), 684-690 (1982).
Joseph M. Muchowski et al., "Synthesis and Antiinflammatory and Analgesic Activity of 5-Aroyl-1,2-dihydro-3H-pyrrolo[1,2-a]pyrrole-1-carboxylic acids . . . ", J. Med. Chem., 30(5), 820-823 (1987).
A.C. Goudie et al., "4,5,8,9-Tetrahydro-8-methyl-9-oxothieno[3'2':5,6]cyclohepta[1,2-b]pyrrole -7-acetic Acids (1). . .", J. Heterocyclic Chem., 20(4),1027-1030 (1983).
Giuliano Nannini et al., "Synthesis and pharmacological activity of some 5,6-diphenyl-pyridazines", Eur. J. Med. Chem.--Chim. Ther., 14(1), 53-60 (1979).
Barnett Jim W.
Dunn James P.
Kertesz Denis J.
Miller Aaron B.
Morgans, Jr. David
Daus Donald G.
Syntex (U.S.A.) Inc.
LandOfFree
Pyrrole pyridazine and pyridazinone anti-inflammatory agents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pyrrole pyridazine and pyridazinone anti-inflammatory agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyrrole pyridazine and pyridazinone anti-inflammatory agents will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-341707